Citadel Advisors
THER

Citadel Advisors’s THERATECHNOLOGIES INC COM THER Stock Holding History

Citadel Advisors’s Portfolio THER Stock Details THER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-34,704
Closed -$29.6K – 15669
2023
Q2 		$29.6K Buy
34,704
+7,277
+27% +$6.2K ﹤0.01% 12365
2023
Q1 		$22.3K Buy
+27,427
New +$22.3K ﹤0.01% 12992
2022
Q4 		– Sell
-29,646
Closed -$70K – 16128
2022
Q3 		$70K Sell
29,646
-10,466
-26% -$24.7K ﹤0.01% 11396
2022
Q2 		$91K Buy
40,112
+25,955
+183% +$58.9K ﹤0.01% 11507
2022
Q1 		$35K Buy
+14,157
New +$35K ﹤0.01% 13030
2021
Q4 		– Sell
-21,625
Closed -$81K – 15614
2021
Q3 		$81K Buy
+21,625
New +$81K ﹤0.01% 13068
2021
Q2 		– Sell
-14,493
Closed -$56K – 15071
2021
Q1 		$56K Buy
+14,493
New +$56K ﹤0.01% 12855
2020
Q2 		– Sell
-12,800
Closed -$21K – 11013
2020
Q1 		$21K Sell
12,800
-30,317
-70% -$49.7K ﹤0.01% 9299
2019
Q4 		$142K Buy
+43,117
New +$142K ﹤0.01% 8391

Other funds holding THER

MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Citadel Advisors's THER Position: Q3 2023 in Review

Citadel Advisors sold out of THERATECHNOLOGIES INC COM (THER) in Q3 2023, closing a stake of 34,704 shares — an estimated $29.6K sold.

Citadel Advisors first reported a position in THER in Q4 2019 and held it in 9 quarters. The position peaked at $142K in Q4 2019. 2 funds tracked by Wall St. Rank hold THER as of Q3 2023.

  • Citadel Advisors reported no remaining THERATECHNOLOGIES INC COM position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 34,704 THERATECHNOLOGIES INC COM shares in Q3 2023, an estimated $29.6K.
  • Citadel Advisors first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 9 quarters.
  • Citadel Advisors's THERATECHNOLOGIES INC COM position peaked at $142K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.